Hemostasis Today

July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Colleen Kelly: Bridging the Access Gap in Gene Therapy for Sickle Cell Disease
Jul 27, 2026, 08:10

Colleen Kelly: Bridging the Access Gap in Gene Therapy for Sickle Cell Disease

Colleen Kelly, Attending Physician and Pediatric Hematologist/Oncologist at Dana-Farber Cancer Institute and Boston Children’s Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Pediatric Blood and Cancer, adding:

“Our new paper is out in Pediatric Blood and Cancer.

Gene therapy can be a transformative treatment for sickle cell disease. But its resource- and time-intensive nature may limit who can actually access it.

In our study, 60% of families with a child with sickle cell disease faced material hardship — food, housing, utility, or transportation insecurity — in the last year.

Only 40% of parents felt they could access gene therapy with their current resources. And families facing material hardship were far less likely to report being able to access this treatment, with 95% lower odds after adjustment.

A transformative therapy is only effective if families can reach it. As these life-changing but resource-intensive therapies expand, access must be part of the design.”

Title: Out of Reach: Understanding Resource Barriers to Gene Therapy for Pediatric Patients With Sickle Cell Disease

Authors: Colleen A. Kelly, Morgan A. Paul, McKenzie Griffin, Sunyu Kang, Rahela Aziz-Bose, Leanne Duhaney, Callie Fry, Puja J. Umaretiya, Kristine Karvonen, Erica Esrick, Sharl Azar, Natasha M. Archer, Kira Bona

Colleen Kelly: Bridging the Access Gap in Gene Therapy for Sickle Cell Disease

Stay updated on all scientific advances with Hemostasis Today.